INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2022, Supplement 3

Cardiovasc Metab Sci 2022; 33 (S3)

Implementation and barriers of high blood pressure guidelines and standards

Guerra-López, Arturo

ABSTRACT

The rapid evolution in medical knowledge, as well as the introduction of Evidence-Based Medicine, have highlighted a need for documents which facilitate acquiring the best information for the benefit of the patient. This has led to the development of medical guidelines in practically all specialties. In the case of high blood pressure (HBP) there are several guidelines developed by diverse Cardiology Societies throughout the world, each of them with different definitions for "normal" values for blood pressure, as well as differences in both management and treatment strategies. Furthermore, guidelines are updated periodically, which increases complexity for the physician to keep up to date. Amongst the barriers which limit physician adherence to the guidelines, are the lack of interest, inadequate medical preparation, excess of information, reliability, or preferences. Physician preference may favor guidelines developed within their country of practice or internationally; however, whichever the preference may be, evidence indicates that adherence to guidelines is generally low. In this review, we recapitulate the evidence on guideline adherence and its potential causes.
  FULL TEXT PDF   FLIPBOOK

Keywords

High blood pressure clinical practice guidelines implementation barriers




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Gym benefits?
    2025, Vol.36, Núm. 2
  • Atherogenic risk profiles and cardiovascular risk assessment in hospitalized...
    2025, Vol.36, Núm. 2
  • Metabolic-Adipose-Cardio-Arterial-Renal-Enterohepatic-Neurological connection...
    2025, Vol.36, Núm. 2
  • Case of coil dislodgement in saphenous vein graft coil occlusion in retrograde...
    2025, Vol.36, Núm. 2
  • Diagnostic challenge: cardiac myeloid sarcoma in a patient with acute myeloid...
    2025, Vol.36, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 33, Num. S3, Julio-Septiembre 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 14 de abril de 2025.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/